Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience

Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience

<h3>Introduction</h3><p dir="ltr">Hepatitis C virus (HCV) infection has detrimental effects on patient and graft survival after kidney transplantation. In the pre-direct-acting antiviral (DAA) era, treatment of HCV infection was associated with low response rates, poor to...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Mohamad M. Alkadi (14778640) (author)
مؤلفون آخرون: Essa A. Abuhelaiqa (14778643) (author), Mostafa F. Elshirbeny (14778646) (author), Ahmed F. Hamdi (14778649) (author), Omar M. Fituri (14778652) (author), Muhammad Asim (2235472) (author), Saad R. Alkaabi (14778655) (author), Moutaz F. Derbala (14778658) (author), Mona E. Jarman (14778661) (author), Adel M. Ashour (14778664) (author), Awais Nauman (14778667) (author), Yousuf K. Al Maslamani (14778670) (author), Adeel A. Butt (3697705) (author), Hassan A. Al‐Malki (14778673) (author)
منشور في: 2020
الموضوعات:
Biomedical and clinical sciences
Clinical sciences
Immunology
hepatitis C
immunosuppression
kidney function
kidney transplantation
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

مواد مشابهة